FDA-AstraZeneca Hearing
Similar Posts
Letter Submitted to New England Journal of Medicine re ARDS Investigation
The April 3, 2003 New England Journal of Medicine (NEJM) issue contained an array of articles largely in support of a disputed multi-site, clinical trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI), one of the National Institutes of Health (NIH), involving critically-ill, mentally incapacitated human beings with acute respiratory distress syndrome (ARDS) – who did not give their informed consent.
The accompanying editorial, "Controlling Research Trials," by Dr. J.M. Drazen, who serves on the NHLBI advisory committee that had approved the disputed trial, reveals much about the NIH attitude toward the rest of the world.
2,610 Infants died of preventable hospital-acquired infections – Chicago Tribune
July 26, 2002 2,610 Infants died of preventable hospital-acquired infections – Chicago Tribune FYI President Bush would limit health care liability http://www.nytimes.com/2002/07/26/politics/26BUSH.html . Clearly neither he nor his advisers have considered The Chicago Tribune’s investigative series, Unhealthy Hospitals (excerpt below). This Tribune series should be required reading for members of the various research…
Nursing Homes: Psychotropic Drug Abuse
In the first half of the twenty-first century, U.S. psychiatrists are prescribing the second generation neuroleptics—Zyprexa, Risperdal, Geodon, Seroquel, Abilfy—to coerce innocent children and the elderly into submission.
Drug Test Loopholes
Subject: Drug Test Loopholes Date: Mon, 7 Oct 2002 09:08:50 -0400 The medical, legal and ethical repercussions of the use of untested medical products–including the smallpox vaccine– have not been publicly debated. Below is a column by Meryl Nass, MD, that appeared online at Redflagsweekly.com in August, addressing the inadequate…
TIME inquiry finds top officials at vital gov agencies lack credentials for the job
TIME inquiry finds top officials at vital gov agencies lack credentials for the job Date: Wed, 28 Sep 2005 The New York Times reports today that the mystery of Lester Crawford’s abrupt resignation as head of the FDA “fueled speculation that he had investments in companies regulated by the FDA."…
Cong. Hinchey calls for ouster of FDA Counsel – Sen. Bingaman & Reed tell FDA: disclose all trial info
Cong. Hinchey calls for ouster of FDA Counsel Sen. Bingaman & Reed tell FDA: disclose all trial info Thu, 15 Jul 2004 Wish I’d said that: “Having Daniel Troy as chief legal counsel of the FDA, is like placing John Gotti in charge of the Justice Department.” (Tom Woodward, whose…